Literature DB >> 1599497

Lipid peroxidation and irreversible damage in the rat hepatocyte model. Protection by the silybin-phospholipid complex IdB 1016.

R Carini1, A Comoglio, E Albano, G Poli.   

Abstract

IdB 1016 is a new silybin-phospholipid complex which is more bioavailable than the flavonoid silybin itself and displays free radical scavenging and antioxidant properties in liver microsomes. We report here that the addition of increasing concentrations of IdB 1016 to isolated rat hepatocytes caused a dose-dependent inhibition of lipid peroxidation induced by ADP-Fe3+ or cumene hydroperoxide. Moreover, IdB 1016 at the concentration which completely prevented MDA formation also protected isolated hepatocytes against the toxicity of pro-oxidant agents such as allyl alcohol, cumene hydroperoxide and bromotrichloromethane, without interfering with the activation mechanism of these xenobiotics. Similar protection was also obtained in hepatocytes prepared from animals pretreated in vivo with IdB 1016 while rat supplementation with pure silybin was totally inefficient. These results indicate IdB 1016 as being a potentially useful protective agent against free radical-mediated toxic liver injury.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1599497     DOI: 10.1016/0006-2952(92)90168-i

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

Review 1.  Silybin and the liver: from basic research to clinical practice.

Authors:  Carmela Loguercio; Davide Festi
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

2.  A conservative triple antioxidant approach to the treatment of hepatitis C. Combination of alpha lipoic acid (thioctic acid), silymarin, and selenium: three case histories.

Authors:  B M Berkson
Journal:  Med Klin (Munich)       Date:  1999-10-15

3.  Protective activity of the stem bark aqueous extract of Musanga cecropioides in carbon tetrachloride- and acetaminophen-induced acute hepatotoxicity in rats.

Authors:  Adejuwon Adewale Adeneye
Journal:  Afr J Tradit Complement Altern Med       Date:  2009-03-07

4.  A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells.

Authors:  Alessandro Federico; Valeria Conti; Giusy Russomanno; Marcello Dallio; Mario Masarone; Paola Stiuso; Concetta Tuccillo; Michele Caraglia; Valentina Manzo; Marcello Persico; Amelia Filippelli; Carmelina Loguercio
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

Review 5.  Review of natural products with hepatoprotective effects.

Authors:  Eduardo Madrigal-Santillán; Eduardo Madrigal-Bujaidar; Isela Álvarez-González; María Teresa Sumaya-Martínez; José Gutiérrez-Salinas; Mirandeli Bautista; Ángel Morales-González; Manuel García-Luna y González-Rubio; J Leopoldo Aguilar-Faisal; José A Morales-González
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 6.  Cosmeceuticals and silibinin.

Authors:  Rana P Singh; Rajesh Agarwal
Journal:  Clin Dermatol       Date:  2009 Sep-Oct       Impact factor: 3.541

7.  Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats.

Authors:  Pragada Rajeswara Rao; Routhu Kasi Viswanath
Journal:  Exp Clin Cardiol       Date:  2007

8.  Hepatoprotective potential of Malvaviscus arboreus against carbon tetrachloride-induced liver injury in rats.

Authors:  Omnia Hesham Abdelhafez; Michael Atef Fawzy; John Refaat Fahim; Samar Yehia Desoukey; Markus Krischke; Martin J Mueller; Usama Ramadan Abdelmohsen
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

9.  Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.

Authors:  Victor J Navarro; Steven H Belle; Massimo D'Amato; Nezam Adfhal; Elizabeth M Brunt; Michael W Fried; K Rajender Reddy; Abdus S Wahed; Stephen Harrison
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

10.  Severe acute respiratory syndrome coronavirus 2 ORF3a induces the expression of ACE2 in oral and pulmonary epithelial cells and the food supplement Vita Deyun® diminishes this effect.

Authors:  Adriana Aguilar-Lemarroy; Apolinar López-Uribe; José Sánchez-Corona; Luis Felipe Jave-Suárez
Journal:  Exp Ther Med       Date:  2021-03-16       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.